 |
|
|
 |
3D Virtual Reality Assisted Neurosurgeons With The Separation Of Conjoined Twins
In what has been called the most difficult conjoined twin separation to date, rehearsals using the Dextroscope, a neurosurgical planning system, greatly assisted the surgeons with their difficult task. The system, developed by a Singapore-based company transforms two-dimensional images of patients' bodies into three-dimensional graphics, allowing neurosurgeons to plan the best way to perform complex surgeries in advance. more
|
|
FDA Approves New Surgical System For The Treatment Of Benign Prostatic Hyperplasia (BPH)
The US Food and Drug Administration (FDA) announced on Friday that it has granted approval to Laserscope to market its new high power KTP laser system specifically for the treatment of Benign Prostatic Hyperplasia (BPH). more
|
|
|
|
FDA Approves Generic Form Of Extended-Release Ritalin
Able Laboratories, a wholly-owned subsidiary of Dynagen, Inc., has received Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) for Methylphenidate Extended Release 20 mg tablets. The approval followed the FDA's Division of Bioequivalence's determination that Able's Methylphenidate Hydrochloride Extended Release Tablets USP, 20 mg, are bioequivalent and, therefore, therapeutically equivalent to the Ritalin-SR(R) 20 mg Tablets of Novartis Pharmaceutical Corporation. more
|
|
Copaxone (Glatiramer Acetate For Injection) Reduces Symptoms And Disease Activity In MS Patients
A study presented this month at the American Academy of Neurology that followed 239 relapsing-remitting multiple sclerosis (MS) patients receiving Copaxone showed sustained reductions in disease activity and disease burden as measured by magnetic resonance imaging (MRI). more
|
|
Prescribing Information: Copaxone (Glatiramer Acetate For Injection)
Glatiramer acetate for injection is one of the most rapidly growing treatments for MS. This non-interferon therapy is indicated for the reduction of relapses in relapsing-remitting multiple sclerosis. Get the full prescribing information in today's issue of Vidyya. more
|
|
|
